David Machover

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Squamous Cell Carcinoma

Top Venues

Scientific reports

The Journal of pharmacology and experimental therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

David Machover, Wathek Almohamad, Vincent Castagné, Christophe Desterke, Léa Gomez, Emma Goldschmidt
Treatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem. Scientific reports 14 (1) (2024)
David Machover, Wathek Almohamad, Vincent Castagné, Christophe Desterke, Léa Gomez, Emma Goldschmidt
Treatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem. Scientific reports 14 (1) (2024)
David Machover, Wathek Almohamad, Vincent Castagné, Christophe Desterke, Léa Gomez, Emma Goldschmidt
Treatment of patients with carcinomas in advanced stages with 5-fluorouracil, folinic acid and pyridoxine in tandem. Scientific reports 14 (1) (2024)
David Machover, Luigia Rossi, Jocelyne Hamelin, Christophe Desterke, Emma Goldschmidt, Bernadette Chadefaux-Vekemans, Pascal Bonnarme, Pierre Briozzo, David Kopečný, Francesca Pierigè, Mauro Magnani, Rosella Mollicone, Farhad Haghighi-Rad, Yann Gaston-Mathé, Julien Dairou, Claude Boucheix, Raphael Saffroy
Effects in Cancer Cells of the Recombinant l-Methionine Gamma-Lyase from Brevibacterium aurantiacum. Encapsulation in Human Erythrocytes for Sustained l-Methionine Elimination. The Journal of pharmacology and experimental therapeutics 369 (3) (2019)
David Machover, Emma Goldschmidt, Rosella Mollicone, Farhad Haghighi-Rad, Christophe Desterke, Yann Gaston-Mathé, Raphael Saffroy, Claude Boucheix, Julien Dairou
Enhancement of 5-Fluorouracil Cytotoxicity by Pyridoxal 5'-Phosphate and Folinic Acid in Tandem. The Journal of pharmacology and experimental therapeutics 366 (2) (2018)